<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/26571?offset=1110</link>
	<atom:link href="https://bioinformaticsonline.com/related/26571?offset=1110" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/videolist/watch/13267/the-genome-10k-project</guid>
	<pubDate>Tue, 29 Jul 2014 09:11:04 -0500</pubDate>
	<link>https://bioinformaticsonline.com/videolist/watch/13267/the-genome-10k-project</link>
	<title><![CDATA[The Genome 10K Project]]></title>
	<description><![CDATA[<iframe width="" height="" src="https://www.youtube-nocookie.com/embed/B57xDIGtCT0" frameborder="0" allowfullscreen></iframe>https://genome10k.soe.ucsc.edu

The Genome 10K project aims to assemble a genomic zoo—a collection of DNA sequences representing the genomes of 10,000 vertebrate species, approximately one for every vertebrate genus. The trajectory of cost reduction in DNA sequencing suggests that this project will be feasible within a few years. Capturing the genetic diversity of vertebrate species would create an unprecedented resource for the life sciences and for worldwide conservation efforts.

The growing Genome 10K Community of Scientists (G10KCOS), made up of leading scientists representing major zoos, museums, research centers, and universities around the world, is dedicated to coordinating efforts in tissue specimen collection that will lay the groundwork for a large-scale sequencing and analysis project.]]></description>
	
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/44412/scientist-positions-csir-institute-of-genomics-integrative-biology-igib</guid>
  <pubDate>Sat, 02 Dec 2023 00:51:08 -0600</pubDate>
  <link></link>
  <title><![CDATA[Scientist positions @ CSIR-Institute of Genomics &amp; Integrative Biology (IGIB)]]></title>
  <description><![CDATA[
<p>CSIR-Institute of Genomics &amp; Integrative Biology (IGIB) is a premier Institute of Council of Scientific<br />and Industrial Research (CSIR), engaged in research of national importance in the areas of genomics,<br />molecular medicine, bioinformatics and proteomics. For more details, kindly refer to website<br />https://igib.res.in.<br />The Institute is looking for dynamic and creative Indian researchers having excellent academic record<br />and interested in Product Development / Technology Innovation / Applied Technology / Translational<br />Research in the above broad areas. The eligible candidates may apply for the following positions<br />through the CSIR-IGIB website.</p>

<p>More at https://www.igib.res.in/bdmg/ScientistRecruitmentAdvt2023.pdf</p>
]]></description>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/13477/research-associate-at-indian-institute-of-chemical-technology-iict-hyderabad</guid>
  <pubDate>Thu, 07 Aug 2014 01:55:21 -0500</pubDate>
  <link></link>
  <title><![CDATA[Research Associate at Indian Institute of Chemical Technology (IICT), Hyderabad]]></title>
  <description><![CDATA[
<p>Indian Institute of Chemical Technology (IICT), Hyderabad, a constituent of CSIR is a leading research Institute in the area of chemical sciences. The core strength of IICT lies in Organic Chemistry, and it continues to excel in this field for over six decades. The research efforts during these years have resulted in the development of several innovative processes for a variety of products necessary for human welfare such as drugs, agrochemicals, food, organic intermediates, adhesives etc. More than 150 technologies developed by IICT are now in commercial production.</p>

<p>CSIR-IICT is conducting Walk in Interview for the following position on a purely temporary basis for the sponsored project "GENESIS (BSC-0121) at 10.00 AM on 19th August 2014 at IICT, Hyderabad</p>

<p>    Position : Research Associate<br />    No of Post : One<br />    Desired Profile : PhD in computation biology or M.Tech in Computational Biology with three years experience in relevant subject and atleast one research paper in SCI journal</p>

<p>    Experience : Knowledge in vector and vector borne disease, disease modeling, GIS mapping and modeling.<br />    Age : 35 years<br />    Stipend : Rs 22000/- + HRA</p>

<p>Eligible candidate may download the application form from our website http://www.iictindia.org and appear for interview along with the duly filled in application form supported by bio-data and one set of attested photo copies of certificates of educational qualification, age, experience, caste, latest photograph and the cadndidates are required to bring all the original certificates for verification</p>

<p>Walk in Interview : 19.08.14</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/blog/view/44713/understanding-rna-seq-normalization-methods-tpm-vs-fpkm-vs-cpm</guid>
	<pubDate>Wed, 11 Dec 2024 00:59:15 -0600</pubDate>
	<link>https://bioinformaticsonline.com/blog/view/44713/understanding-rna-seq-normalization-methods-tpm-vs-fpkm-vs-cpm</link>
	<title><![CDATA[Understanding RNA-Seq Normalization Methods: TPM vs. FPKM vs. CPM]]></title>
	<description><![CDATA[<p>RNA sequencing (RNA-Seq) is a powerful technology used to study transcriptomes, providing insights into gene expression levels. However, raw RNA-Seq data requires normalization to account for sequencing depth and gene length, enabling accurate comparisons between genes and samples. Among the most widely used normalization methods are TPM (Transcripts Per Million), FPKM (Fragments Per Kilobase Million), and CPM (Counts Per Million). Each method has its unique principles and applications, which we&rsquo;ll explore in this blog.</p><h2>Why Normalize RNA-Seq Data?</h2><p>Normalization is a crucial step in RNA-Seq analysis for the following reasons:</p><ul>
<li>
<p><strong>Sequencing depth:</strong> Different RNA-Seq experiments produce varying numbers of reads, making direct comparisons between samples misleading.</p>
</li>
<li>
<p><strong>Gene length:</strong> Longer genes inherently generate more reads, irrespective of their actual expression level.</p>
</li>
<li>
<p><strong>Bias reduction:</strong> Normalization mitigates technical biases, enabling meaningful biological interpretation.</p>
</li>
</ul><h2>TPM (Transcripts Per Million)</h2><p>TPM measures the proportion of reads mapped to a transcript, normalized by transcript length and sequencing depth. It is calculated as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Proportionality:</strong> TPM values sum to 1,000,000 across all transcripts in a sample, making it easier to compare between samples.</p>
</li>
<li>
<p><strong>Intuitive interpretation:</strong> TPM values directly represent the abundance of transcripts in a sample.</p>
</li>
<li>
<p><strong>Preferred for comparisons:</strong> TPM facilitates between-sample comparisons better than FPKM.</p>
</li>
</ol><h2>FPKM (Fragments Per Kilobase Million)</h2><p>FPKM normalizes read counts by transcript length and sequencing depth, but without enforcing proportionality like TPM. It is defined as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Historical significance:</strong> FPKM was one of the first normalization methods used for RNA-Seq.</p>
</li>
<li>
<p><strong>Single-end vs. paired-end:</strong> In paired-end sequencing, FPKM becomes RPKM (Reads Per Kilobase Million).</p>
</li>
<li>
<p><strong>Limited utility:</strong> FPKM values are not as robust as TPM for cross-sample comparisons due to lack of proportionality.</p>
</li>
</ol><h2>CPM (Counts Per Million)</h2><p>CPM normalizes raw read counts by sequencing depth, without considering gene length. It is expressed as:</p><h3>Key Features:</h3><ol>
<li>
<p><strong>Simplicity:</strong> CPM is straightforward and computationally less intensive.</p>
</li>
<li>
<p><strong>Application:</strong> Suitable for non-length-dependent analyses, such as comparing total expression levels or differential expression analysis.</p>
</li>
<li>
<p><strong>Gene length agnostic:</strong> CPM does not correct for gene length, making it less ideal for measuring expression levels.</p>
</li>
</ol><h2>When to Use Each Method</h2><ul>
<li>
<p><strong>TPM:</strong> Best for comparing expression levels between samples, especially when transcript length and sequencing depth vary.</p>
</li>
<li>
<p><strong>FPKM:</strong> Useful for historical consistency but generally replaced by TPM.</p>
</li>
<li>
<p><strong>CPM:</strong> Ideal for differential expression analysis when gene length normalization is unnecessary.</p>
</li>
</ul><h2>Conclusion</h2><p>Choosing the right normalization method depends on the specific objectives of your RNA-Seq analysis. TPM&rsquo;s proportionality and robustness make it the preferred choice for most applications, while CPM serves well for differential expression studies. Although FPKM paved the way for RNA-Seq normalization, it has largely been supplanted by TPM in modern workflows. Understanding these methods and their nuances ensures accurate and meaningful interpretations of RNA-Seq data.</p><h3>References:</h3><ol>
<li>
<p>Li, B., &amp; Dewey, C. N. (2011). RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. <em>BMC Bioinformatics.</em></p>
</li>
<li>
<p>Trapnell, C., et al. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. <em>Nature Biotechnology.</em></p>
</li>
<li>
<p>Law, C. W., et al. (2014). voom: precision weights unlock linear model analysis tools for RNA-seq read counts. <em>Genome Biology.</em></p>
</li>
</ol>]]></description>
	<dc:creator>Neel</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/3885/precision-medicine</guid>
	<pubDate>Sat, 24 Aug 2013 15:47:03 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/3885/precision-medicine</link>
	<title><![CDATA[Precision Medicine]]></title>
	<description><![CDATA[<p>Coupling established clinical&ndash;pathological indexes with state-of-the-art molecular profiling to create diagnostic, prognostic, and therapeutic strategies precisely tailored to each patient's requirements &mdash; hence the term &ldquo;Precision medicine&rdquo;&nbsp;</p>
<p>Source:<a href="http://www.nejm.org/doi/full/10.1056/NEJMp1114866">http://www.nejm.org/doi/full/10.1056/NEJMp1114866</a></p>
<p><strong>Another video on precision medicine</strong>:</p>
<p><a href="http://www.youtube.com/watch?v=Pi8W0yOXnzE">http://www.youtube.com/watch?v=Pi8W0yOXnzE</a></p>
<p>Precision Medicine basically intergrates bioinformatics, genomics , genetics, molecular biology and nanotechnology to deliver precise cure/diagnotics to a specific patient.</p>
<p>Examples:</p>
<ul>
<li><span>The drug imatinib (Gleevec) designed to inhibit an altered enzyme produced by a fused version of two genes found in chronic myelogenous leukemia.</span></li>
<li><span>The breast cancer drug trastuzumab (Herceptin) works only for women whose tumors have a particular genetic profile called HER-2 positive.</span></li>
</ul>
<p><span>E.g. source :</span></p>
<p><span><a href="http://www.bionews-tx.com/news/2013/08/15/how-the-impact-of-cancer-genomics-on-precision-medicine-is-revolutionizing-cancer-treatment/">http://www.bionews-tx.com/news/2013/08/15/how-the-impact-of-cancer-genomics-on-precision-medicine-is-revolutionizing-cancer-treatment/</a></span></p><p>Address of the bookmark: <a href="http://www.cbsnews.com/video/watch/?id=50149783n" rel="nofollow">http://www.cbsnews.com/video/watch/?id=50149783n</a></p>]]></description>
	<dc:creator>Rahul Agarwal</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/14054/project-fellow-at-institute-of-himalayan-bioresource-technology</guid>
  <pubDate>Fri, 15 Aug 2014 06:50:08 -0500</pubDate>
  <link></link>
  <title><![CDATA[Project Fellow at Institute of Himalayan Bioresource Technology]]></title>
  <description><![CDATA[
<p>Research Associate/ Project FellowDate of posting:14 Aug</p>

<p>Eligibility : MSc, M Phil / Phd, BE/B.Tech<br />Location : Himachal Pradesh-other<br />Job Category : Govt Jobs, Research, Walkin<br />Last Date : 20 Aug 2014</p>

<p>Advertisement No.6/2014</p>

<p>Post : Project Fellow<br />Research Associate/ Project Fellow Jobs opportunity in CSIR-Institute of Himalayan Bioresource Technology<br />M.Sc. in Bioinformatics/Computer Science with 55% marks and (ii) M.Sc. Bioinformatics/ Computational biology/ P.G. Diploma in Bioinformatics/B.Tech. or higher Degree in Bioinformatics with 55% marks</p>

<p>Date of Interview: 29.08.2014.</p>

<p>More at http://www.ihbt.res.in/recruit/AdvtNo6_2014.pdf</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/34485/phyloxml-xml-for-evolutionary-biology-and-comparative-genomics</guid>
	<pubDate>Wed, 29 Nov 2017 10:04:48 -0600</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/34485/phyloxml-xml-for-evolutionary-biology-and-comparative-genomics</link>
	<title><![CDATA[phyloXML:  XML for evolutionary biology and comparative genomics]]></title>
	<description><![CDATA[<p><a href="http://www.biomedcentral.com/1471-2105/10/356/">phyloXML</a><span>&nbsp;(</span><a href="http://www.phyloxml.org/examples_syntax/phyloxml_syntax_example_1.html">example</a><span>) is an&nbsp;</span><a href="http://en.wikipedia.org/wiki/XML">XML</a><span>&nbsp;language designed to describe phylogenetic trees (or networks) and associated data. PhyloXML provides elements for commonly used features, such as taxonomic information, gene names and identifiers, branch lengths, support values, and gene duplication and speciation events. Using these standardized elements allows interoperability between various applications and databases. Furthermore, both due to extensible nature of XML itself and the provision of &lt;property&gt; elements by phyloXML, extensibility as well as domain specific applications are ensured. The structure of phyloXML is described by&nbsp;</span><a href="http://en.wikipedia.org/wiki/XML_Schema_%28W3C%29">XML Schema Definition (XSD)</a><span>&nbsp;language.</span></p><p>Address of the bookmark: <a href="http://www.phyloxml.org/" rel="nofollow">http://www.phyloxml.org/</a></p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/videolist/watch/14338/biology-computers-collide-in-high-demand-field-of-bioinformatics</guid>
	<pubDate>Mon, 25 Aug 2014 00:56:10 -0500</pubDate>
	<link>https://bioinformaticsonline.com/videolist/watch/14338/biology-computers-collide-in-high-demand-field-of-bioinformatics</link>
	<title><![CDATA[Biology, Computers Collide in High-Demand Field of Bioinformatics]]></title>
	<description><![CDATA[<iframe width="" height="" src="https://www.youtube-nocookie.com/embed/fk0z7KOTyMo" frameborder="0" allowfullscreen></iframe>Dr. Shivas Amin calls bioinformatics a "collision of biology and computers." Students learn how to use computers and skills in math and biology to analyze genome and proteome projects to prepare for high-demand jobs in the life sciences. Learn more about Amin and hear from student Medina Baitemirova and alumnus Lukas Simon about the fast-growing field of bioinformatics.]]></description>
	
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/36267/pspairwise-sequentially-markovian-coalescent-psmc-model</guid>
	<pubDate>Thu, 19 Apr 2018 05:29:23 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/36267/pspairwise-sequentially-markovian-coalescent-psmc-model</link>
	<title><![CDATA[PSPairwise Sequentially Markovian Coalescent (PSMC) model]]></title>
	<description><![CDATA[<p><span>Implementation of the Pairwise Sequentially Markovian Coalescent (PSMC) model</span></p><p>Address of the bookmark: <a href="https://github.com/lh3/psmc" rel="nofollow">https://github.com/lh3/psmc</a></p>]]></description>
	<dc:creator>Jit</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/news/view/14800/a-comprehensive-atlas-of-human-gene-activity-released</guid>
	<pubDate>Tue, 02 Sep 2014 14:20:24 -0500</pubDate>
	<link>https://bioinformaticsonline.com/news/view/14800/a-comprehensive-atlas-of-human-gene-activity-released</link>
	<title><![CDATA[A comprehensive atlas of human gene activity released !!!]]></title>
	<description><![CDATA[<div><div id="postDescription_4018558404"><p>A large international consortium of researchers has produced the first comprehensive, detailed map of the way&nbsp;<a href="http://www.hsph.harvard.edu/news/topic/genetics/" target="_blank">genes</a>&nbsp;work across the major cells and tissues of the human body. The findings describe the complex networks that govern gene activity, and the new information could play a crucial role in identifying the genes involved with disease.</p><p><img src="http://www.kurzweilai.net/images/Coexpression-clustering.jpg" alt="image" width="640" height="460" style="border: 0px; border: 0px;"></p><p>We are able to pinpoint the regions of the genome that can be active in a disease and in normal activity, whether it&rsquo;s in a brain cell, the skin, in blood stem cells or in hair follicles. This is a major advance that will greatly increase our ability to understand the causes of disease across the body.</p><p>The research is outlined in a series of papers published March 27, 2014, two in the journal&nbsp;<em>Nature</em>&nbsp;and 16 in other scholarly journals. The work is the result of years of concerted effort among 250 experts from more than 20 countries as part of&nbsp;<a href="http://fantom.gsc.riken.jp/" target="_blank">FANTOM 5 (Functional Annotation of the Mammalian Genome)</a>. The FANTOM project, led by the Japanese institution RIKEN, is aimed at building a complete library of human genes.</p><p>Researchers studied human and mouse cells using a new technology called Cap Analysis of Gene Expression (CAGE), developed at RIKEN, to discover how 95% of all human genes are switched on and off. These &ldquo;switches&rdquo; &mdash; called &ldquo;promoters&rdquo; and &ldquo;enhancers&rdquo; &mdash; are the regions of DNA that manage gene activity. The researchers mapped the activity of 180,000 promoters and 44,000 enhancers across a wide range of human cell types and tissues and, in most cases, found they were linked with specific cell types.</p><p>Referene : www.kurzweilai.net/first-comprehensive-atlas-of-human-gene-activity-released</p></div></div>]]></description>
	<dc:creator>Abhimanyu Singh</dc:creator>
</item>

</channel>
</rss>